Patents by Inventor Tokuaki Kajiho

Tokuaki Kajiho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Remedies for male sterility
    Patent number: 6521656
    Abstract: Efficacious remedies for male sterility which are in the form of preparations containing as the active ingredient an adenosine A1 antagonist.
    Type: Grant
    Filed: January 4, 2001
    Date of Patent: February 18, 2003
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Satoru Kaneko, Kazuhiko Nomura, Yutaka Kohno, Hiroshi Kodama, Tokuaki Kajiho
  • Preventives and remedies for hyperphosphatemia
    Patent number: 6303624
    Abstract: This invention has for its object to provide a pharmaceutical composition for the prevention and/or treatment of hyperphosphatemia and secondary hyperparathyroidism, inclusive of their accessory disorders and symptoms. The object is accomplished by provision of a pharmaceutical composition comprising an adenosine antagonist as an active ingredient.
    Type: Grant
    Filed: November 4, 1999
    Date of Patent: October 16, 2001
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Kazuhiko Nomura, Emiko Sasaki, Kazumi Nakazi, Tokuaki Kajiho
  • Use of pyrazolopyridine compound
    Patent number: 6232324
    Abstract: The present invention relates to a pharmaceutical composition for the prevention and/or the treatment of dialysis-induced hypotension and/or hypotension after dialysis which comprises, as an active ingredient, a pyrazolopyridine compound of the following formula wherein the groups R1, R2 R3, or a said thereof are herein defined.
    Type: Grant
    Filed: October 24, 1997
    Date of Patent: May 15, 2001
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Hiroyuki Mizuo, Tokuaki Kajiho, Haruo Horiai, Yukio Motoyama, Kimio Esumi
  • Sustained release tablet
    Patent number: 4695467
    Abstract: The invention relates to a sustained release tablet which comprises easily disintegrable granules containing(a) a drug,(b) a disintegrating agent selected from the group consisting of starch derivatives, gums, cellulose derivatives and ion-exchange resins, and(c) a water soluble polymer selected from the group consisting of cellulose derivatives, synthetic water soluble polymers and polysaccharides, the surfaces of which granules are treated solely with a wax selected from the group consisting of plant or animal wax, hydrogenated oils and paraffin.
    Type: Grant
    Filed: July 5, 1985
    Date of Patent: September 22, 1987
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Toshinobu Uemura, Kiyohide Shinooka, Tokuaki Kajiho